BE682551A - - Google Patents

Info

Publication number
BE682551A
BE682551A BE682551DA BE682551A BE 682551 A BE682551 A BE 682551A BE 682551D A BE682551D A BE 682551DA BE 682551 A BE682551 A BE 682551A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE682551A publication Critical patent/BE682551A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE682551D 1965-06-15 1966-06-15 BE682551A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
BE682551A true BE682551A (pt) 1966-11-14

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
BE682551D BE682551A (pt) 1965-06-15 1966-06-15

Country Status (14)

Country Link
AT (1) AT272530B (pt)
BE (1) BE682551A (pt)
BR (1) BR6680359D0 (pt)
CH (1) CH558362A (pt)
DE (1) DE1620206A1 (pt)
DK (1) DK115926B (pt)
ES (1) ES327925A1 (pt)
FI (1) FI49724C (pt)
FR (1) FR6395M (pt)
GB (1) GB1136214A (pt)
LU (1) LU51306A1 (pt)
NL (1) NL6608255A (pt)
NO (1) NO119590B (pt)
SE (1) SE325276B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) * 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
WO2006091885A2 (en) 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2010014229A1 (en) * 2008-07-30 2010-02-04 Purdue Pharma L.P. Buprenorphine analogs
CA2738758C (en) * 2008-09-30 2016-11-29 Mallinckrodt Inc. Processes for the alkylation of norbuprenorphine with reduced impurity formation
AU2010239059B2 (en) 2009-04-24 2016-06-09 Brock University Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
ES2647516T3 (es) 2011-12-12 2017-12-22 Lts Lohmann Therapie-Systeme Ag Sistema de administración transdérmica que comprende buprenorfina
EP3791861A1 (en) 2012-07-26 2021-03-17 Camurus AB Opioid formulations
US9175000B2 (en) * 2012-12-07 2015-11-03 Purdue Pharma L.P. Buprenorphine analogs
SI2810646T1 (sl) 2013-06-04 2016-11-30 Lts Lohmann Therapie-Systeme Ag Transdermalni sistem za dajanje
CA3238849A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
LU51306A1 (pt) 1966-08-16
ES327925A1 (es) 1967-04-01
NO119590B (pt) 1970-06-08
SE325276B (pt) 1970-06-29
FR6395M (pt) 1968-10-21
NL6608255A (pt) 1966-12-16
BR6680359D0 (pt) 1973-12-26
DK115926B (da) 1969-11-24
CH558362A (de) 1975-01-31
FI49724B (pt) 1975-06-02
DE1620206A1 (de) 1970-03-19
FI49724C (fi) 1975-09-10
GB1136214A (en) 1968-12-11
AT272530B (de) 1969-07-10

Similar Documents

Publication Publication Date Title
JPS4515345Y1 (pt)
JPS45252Y1 (pt)
JPS4317802Y1 (pt)
JPS4217892Y1 (pt)
JPS444955Y1 (pt)
JPS4525468Y1 (pt)
BE672602A (pt)
BE671542A (pt)
BE673306A (pt)
BE672918A (pt)
NL6615906A (pt)
BE672882A (pt)
NL6614768A (pt)
BE672852A (pt)
BE672779A (pt)
BE672770A (pt)
BE674593A (pt)
BE672765A (pt)
BE675676A (pt)
BE672691A (pt)
BE675572A (pt)
BE675466A (pt)
NL6611029A (pt)
BE672690A (pt)
BE685406A (pt)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: RECKITT & SONS LTD

Effective date: 19860615